Search - tctmd.com

Displaying 41 - 60 of 67

Sort: Relevancy | Date

News Daily News

FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients

Yael L. Maxwell

May 16, 2019

News Daily News

Unrecognized Obstructive Sleep Apnea Linked to CV Complications After Noncardiac Surgery

L.A. McKeown

May 14, 2019

News Conference News HRS 2019

Cancer Survivors With Heart Failure Respond Well to CRT

Todd Neale

May 14, 2019

News Daily News

Experts Call on Training Programs to Incorporate Cardio-Oncology to Meet Growing Need

L.A. McKeown

April 30, 2019

News Daily News

Sitting Kills, in a Dose-Response Fashion, but Regular Physical Activity Attenuates Risks

Yael L. Maxwell

April 25, 2019

News Opinion Fellow Talk

Public Reporting and the Budding Interventional Cardiologist

Yashasvi Chugh, MD

March 28, 2019

News Daily News

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

L.A. McKeown

March 21, 2019

News Conference News CRT 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

L.A. McKeown

March 06, 2019

News Daily News

Signal of Aortic Stenosis Risk With Celecoxib

Michael O'Riordan

March 05, 2019

News Daily News

Updated AHA Scientific Statement Addresses CV Risk Reduction in High-Risk Youth

Todd Neale

March 05, 2019

News Daily News

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

Todd Neale

March 04, 2019

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

L.A. McKeown

March 01, 2019

News Daily News

New Equations Help ID Patients at Low Risk for Bleeding With Aspirin

Michael O'Riordan

February 26, 2019

News Daily News

Breast Calcifications May Hold Important Clues for CV Risk Stratification

L.A. McKeown

February 22, 2019

News Daily News

Human Papilloma Virus May Contribute to CVD Risk in Women, Korean Study Finds

L.A. McKeown

February 08, 2019

News Daily News

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

Michael O'Riordan

February 08, 2019

News Conference News STS 2019

No ‘July Effect’ Observed in Cardiac Surgery

Yael L. Maxwell

February 05, 2019

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

News Daily News

AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline

Michael O'Riordan

January 29, 2019

News Daily News

Aspirin as Primary Prevention Curbs CV Events but Ups Major Bleeding, Too: Meta-analysis

Caitlin E. Cox

January 24, 2019

Advertisement

FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients

Unrecognized Obstructive Sleep Apnea Linked to CV Complications After Noncardiac Surgery

Cancer Survivors With Heart Failure Respond Well to CRT

Experts Call on Training Programs to Incorporate Cardio-Oncology to Meet Growing Need

Sitting Kills, in a Dose-Response Fashion, but Regular Physical Activity Attenuates Risks

Public Reporting and the Budding Interventional Cardiologist

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

Signal of Aortic Stenosis Risk With Celecoxib

Updated AHA Scientific Statement Addresses CV Risk Reduction in High-Risk Youth

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

New Equations Help ID Patients at Low Risk for Bleeding With Aspirin

Breast Calcifications May Hold Important Clues for CV Risk Stratification

Human Papilloma Virus May Contribute to CVD Risk in Women, Korean Study Finds

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

No ‘July Effect’ Observed in Cardiac Surgery

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline

Aspirin as Primary Prevention Curbs CV Events but Ups Major Bleeding, Too: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content